Your family history could hold critical clues about your health. By combining cutting-edge technology with genetic research, OSF Innovation is empowering physicians with information that fosters a more personalized approach to care, potentially saving lives.

Join us as we explore how OSF Innovation is leveraging artificial intelligence (AI) to analyze medical records and identify individuals who may be at risk for familial hypercholesterolemia (FH). Often undiagnosed, FH is a genetic condition that causes dangerously high levels of LDL cholesterol, increasing the risk of heart disease, heart attacks and strokes, even in younger adults. For people with FH, early detection is key to preventing life-threatening complications.

Host Shelli Dankoff chats with Darrel Gumm, MD, vice president of OSF HealthCare Cardiovascular Institute, and Ryan Loudermilk, a strategic program manager in Performance Improvement at OSF Innovation about how AI-driven insights are transforming the way FH is detected and managed. Learn how this innovative approach to personalized medicine is making heart health more proactive and precise than ever before.

Speaker highlight:

Darrel Gumm, MD

Vice President

OSF HealthCare Cardiovascular Institute

Ryan Loudermilk

Strategic Program Manager, Performance Improvement

OSF Innovation

Connect with us at www.osfhealthcare.org/accelerated